Literature DB >> 22718398

The faces and friends of RhoGDI2.

Erin M Griner1, Dan Theodorescu.   

Abstract

RhoGDI2 is a guanine nucleotide dissociation inhibitor (GDI) specific for the Rho family of small GTPases that plays dual opposite roles in tumor progression, being both a promoter in tissues such as breast and a metastasis suppressor in tissues such as the bladder. Despite a clear role for this protein in modulating the invasive and metastatic process, the mechanisms through which RhoGDI2 executes these functions remain unclear. This review will highlight the current state of our knowledge regarding how RhoGDI2 functions in metastasis with a focus on bladder cancer and will also seek to highlight other potential underappreciated avenues through which this protein may affect cancer cell behavior.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718398     DOI: 10.1007/s10555-012-9376-6

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  11 in total

Review 1.  Metastasis suppressors in breast cancers: mechanistic insights and clinical potential.

Authors:  Christopher R Bohl; Sitaram Harihar; Warren L Denning; Rahul Sharma; Danny R Welch
Journal:  J Mol Med (Berl)       Date:  2013-12-06       Impact factor: 4.599

Review 2.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Authors:  Margaret A Knowles; Carolyn D Hurst
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

3.  An adventitious interaction of filamin A with RhoGDI2(Tyr153Glu).

Authors:  Mia Song; Qianjing He; Benjamin-Andreas Berk; John H Hartwig; Thomas P Stossel; Fumihiko Nakamura
Journal:  Biochem Biophys Res Commun       Date:  2015-12-17       Impact factor: 3.575

4.  RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells.

Authors:  Zhong Zheng; Bingya Liu; Xiaohua Wu
Journal:  Cancer Cell Int       Date:  2015-04-15       Impact factor: 5.722

5.  Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs.

Authors:  Takahide Ota; Masayo Maeda; Mayumi Okamoto; Masaaki Tatsuka
Journal:  BMC Syst Biol       Date:  2015-01-28

6.  Apoptosis‑independent cleavage of RhoGDIβ at Asp19 during PMA‑stimulated differentiation of THP‑1 cells to macrophages.

Authors:  Takahide Ota; Yong-Sheng Jiang; Mamoru Fujiwara; Masaaki Tatsuka
Journal:  Mol Med Rep       Date:  2017-02-13       Impact factor: 2.952

7.  Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.

Authors:  Daniela Cecconi; Jessica Brandi; Marcello Manfredi; Michela Serena; Luca Dalle Carbonare; Michela Deiana; Samuele Cheri; Francesca Parolini; Alberto Gandini; Giulia Marchetto; Giulio Innamorati; Francesco Avanzi; Franco Antoniazzi; Emilio Marengo; Natascia Tiso; Monica Mottes; Donato Zipeto; Maria Teresa Valenti
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

8.  Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.

Authors:  Elaine J Gauson; Brad Windle; Mary M Donaldson; Maria M Caffarel; Edward S Dornan; Nicholas Coleman; Pawel Herzyk; Scott C Henderson; Xu Wang; Iain M Morgan
Journal:  Virology       Date:  2014-08-16       Impact factor: 3.616

9.  Lentivirus-mediated knockdown of P27RF-Rho inhibits hepatocellular carcinoma cell growth.

Authors:  Shuli Xie; Guangyi Wang; Guofu Chen; Mingguang Zhu; Guoyue Lv
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22

Review 10.  A Review on the Function and Regulation of ARHGDIB/RhoGDI2 Expression Including the Hypothetical Role of ARHGDIB/RhoGDI2 Autoantibodies in Kidney Transplantation.

Authors:  Tineke Kardol-Hoefnagel; Sofie A L M van Logtestijn; Henny G Otten
Journal:  Transplant Direct       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.